Durham, NC, United States of America

John Scott

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Inventor John Scott

Introduction

John Scott is a distinguished inventor based in Durham, NC, whose work has led to the development of two notable patents. His innovative contributions primarily focus on compounds that function as glucuronidase inhibitors, showcasing valuable applications in the medical field.

Latest Patents

Scott's latest patents include noteworthy inventions:

1. **Phenoxy thiophene sulfonamides and their use as inhibitors of glucuronidase**: This invention pertains to compounds that serve as glucuronidase inhibitors. It encompasses phenoxy thiophene sulfonamides and other compounds such as pyridine sulfonyls, benzene sulfonyls, thiophene sulfonyls, thiazole sulfonyls, thiophene carbonyls, and thiazole carbonyls. The patent also covers compositions that include these compounds aimed at inhibiting glucuronidase and their use in conjunction with the anticancer drug CPT-11.

2. **Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents**: This patent presents compounds and methods designed to inhibit bacterial beta-glucuronidases, particularly for those associated with the gastrointestinal tract. The focus is on improving the efficacy of camptothecin-derived antineoplastic agents while mitigating the side effects caused by bacterial reactivation of glucuronidated metabolites of these agents.

Career Highlights

Throughout his career, John Scott has made significant strides in research and innovation, working with reputable institutions like North Carolina Central University and the University of North Carolina at Chapel Hill. His dedication to advancing the field of medicine is evident through his patent contributions and ongoing research endeavors.

Collaborations

John Scott has collaborated with esteemed colleagues, including Matthew Robert Redinbo and Alfred L. Williams. These partnerships have enriched his research and have played a crucial role in the development of his innovations.

Conclusion

John Scott stands out as an inventor whose work has far-reaching implications, especially in the area of cancer treatment through glucuronidase inhibition. With his two patents, he demonstrates a commitment to enhancing medical treatments and improving patient outcomes, making noteworthy contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…